LINC00266-1 BA476I15.3: A Potential Drug Target for Cancer and Other Diseases

Target Name: LINC00266-1

NCBI ID: G140849

LINC00266-1

LINC00266-1 BA476I15.3: A Potential Drug Target for Cancer and Other Diseases

LINC00266-1 (bA476I15.3) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a key regulator of the cell cycle, and is known for its role in the development and progression of various diseases, including cancer.

Recent studies have identified LINC00266-1 (bA476I15.3) as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. This is because LINC00266-1 (bA476I15.3) is involved in the regulation of cell division, and many diseases are caused by disruptions in cell division.

One of the ways that LINC00266-1 (bA476I15.3) is involved in cell division is by regulating the activity of the tumor suppressor protein, p53. P53 is a key regulator of the cell cycle, and is often disrupted in cancer cells. LINC00266-1 (bA476I15.3) has been shown to interact with p53 and to regulate its activity.

Another way that LINC00266-1 (bA476I15.3) is involved in cancer is by promoting the growth and survival of cancer cells. Many studies have shown that LINC00266-1 (bA476I15.3) is highly expressed in various tissues of cancer, and that it plays a key role in the growth and survival of cancer cells.

In addition to its involvement in cell division and cancer growth, LINC00266-1 (bA476I15.3) is also involved in the regulation of the immune system. Many studies have shown that LINC00266-1 (bA476I15.3) is highly expressed in immune cells, and that it plays a key role in the regulation of immune responses.

Overall, LINC00266-1 (bA476I15.3) is a protein that is involved in a wide range of processes in the body, including cell division, cancer growth, and immune regulation. As a result, it is a promising target for the development of new drugs for the treatment of various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 266-1

The "LINC00266-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00266-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets